GlaxoSmithKline PLC Stock Forecast - Polynomial Regression
| GSK Stock | USD 40.50 0.16 0.39% |
The Polynomial Regression forecasted value of GlaxoSmithKline PLC ADR on the next trading day is expected to be 39.81 with a mean absolute deviation of 0.41 and the sum of the absolute errors of 24.89. GlaxoSmithKline Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC stock prices and determine the direction of GlaxoSmithKline PLC ADR's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of GlaxoSmithKline PLC's historical fundamentals, such as revenue growth or operating cash flow patterns. Although GlaxoSmithKline PLC's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of GlaxoSmithKline PLC's systematic risk associated with finding meaningful patterns of GlaxoSmithKline PLC fundamentals over time.
Check out Historical Fundamental Analysis of GlaxoSmithKline PLC to cross-verify your projections. GlaxoSmithKline |
Open Interest Against 2024-04-19 GlaxoSmithKline Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast GlaxoSmithKline PLC's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in GlaxoSmithKline PLC's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for GlaxoSmithKline PLC stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current GlaxoSmithKline PLC's open interest, investors have to compare it to GlaxoSmithKline PLC's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of GlaxoSmithKline PLC is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in GlaxoSmithKline. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in GlaxoSmithKline PLC cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the GlaxoSmithKline PLC's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets GlaxoSmithKline PLC's price structures and extracts relationships that further increase the generated results' accuracy.
GlaxoSmithKline PLC polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for GlaxoSmithKline PLC ADR as well as the accuracy indicators are determined from the period prices. GlaxoSmithKline PLC Polynomial Regression Price Forecast For the 16th of April 2024
Given 90 days horizon, the Polynomial Regression forecasted value of GlaxoSmithKline PLC ADR on the next trading day is expected to be 39.81 with a mean absolute deviation of 0.41, mean absolute percentage error of 0.24, and the sum of the absolute errors of 24.89.Please note that although there have been many attempts to predict GlaxoSmithKline Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that GlaxoSmithKline PLC's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
GlaxoSmithKline PLC Stock Forecast Pattern
| Backtest GlaxoSmithKline PLC | GlaxoSmithKline PLC Price Prediction | Buy or Sell Advice |
GlaxoSmithKline PLC Forecasted Value
In the context of forecasting GlaxoSmithKline PLC's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. GlaxoSmithKline PLC's downside and upside margins for the forecasting period are 38.90 and 40.72, respectively. We have considered GlaxoSmithKline PLC's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of GlaxoSmithKline PLC stock data series using in forecasting. Note that when a statistical model is used to represent GlaxoSmithKline PLC stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.6872 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4081 |
| MAPE | Mean absolute percentage error | 0.0099 |
| SAE | Sum of the absolute errors | 24.8944 |
Predictive Modules for GlaxoSmithKline PLC
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GlaxoSmithKline PLC ADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlaxoSmithKline PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for GlaxoSmithKline PLC
For every potential investor in GlaxoSmithKline, whether a beginner or expert, GlaxoSmithKline PLC's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. GlaxoSmithKline Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in GlaxoSmithKline. Basic forecasting techniques help filter out the noise by identifying GlaxoSmithKline PLC's price trends.GlaxoSmithKline PLC Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GlaxoSmithKline PLC stock to make a market-neutral strategy. Peer analysis of GlaxoSmithKline PLC could also be used in its relative valuation, which is a method of valuing GlaxoSmithKline PLC by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
GlaxoSmithKline PLC ADR Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of GlaxoSmithKline PLC's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of GlaxoSmithKline PLC's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
GlaxoSmithKline PLC Market Strength Events
Market strength indicators help investors to evaluate how GlaxoSmithKline PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GlaxoSmithKline PLC shares will generate the highest return on investment. By undertsting and applying GlaxoSmithKline PLC stock market strength indicators, traders can identify GlaxoSmithKline PLC ADR entry and exit signals to maximize returns.
| Accumulation Distribution | 50943.12 | |||
| Daily Balance Of Power | (0.26) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 40.75 | |||
| Day Typical Price | 40.67 | |||
| Price Action Indicator | (0.33) | |||
| Period Momentum Indicator | (0.16) | |||
| Relative Strength Index | 43.12 |
GlaxoSmithKline PLC Risk Indicators
The analysis of GlaxoSmithKline PLC's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in GlaxoSmithKline PLC's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting glaxosmithkline stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.6687 | |||
| Semi Deviation | 0.8012 | |||
| Standard Deviation | 0.9104 | |||
| Variance | 0.8288 | |||
| Downside Variance | 0.7425 | |||
| Semi Variance | 0.642 | |||
| Expected Short fall | (0.70) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of GlaxoSmithKline PLC to cross-verify your projections. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for GlaxoSmithKline Stock analysis
When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 0.58 | Earnings Share 3 | Revenue Per Share 14.97 | Quarterly Revenue Growth 0.092 |
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.